Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02731976
Other study ID # M12.113965
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2011
Est. completion date May 2014

Study information

Verified date April 2024
Source University Medical Center Groningen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Changes in the gut microbiomes of healthy volunteers who followed a gluten-free diet (GFD) for four weeks were studied. Per participant, nine stool samples were collected: one at baseline, four during the GFD period, and four when they returned to their habitual diet. Microbiome profiles were determined using 16S rRNA sequencing and the samples were next processed for taxonomic and imputed functional composition. Additionally, participants kept a 3-day food diary and six gut health-related biomarkers were measured.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date May 2014
Est. primary completion date February 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - healthy participants aged >=16 Exclusion Criteria: - Known gastrointestinal disorder - Known food intolerance

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Dietary intervention


Locations

Country Name City State
Netherlands University Medical Center Groningen Groningen

Sponsors (1)

Lead Sponsor Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

References & Publications (1)

Baranska A, Tigchelaar E, Smolinska A, Dallinga JW, Moonen EJ, Dekens JA, Wijmenga C, Zhernakova A, van Schooten FJ. Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet. J Breath Res. 2013 Sep;7(3):037104. doi: — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in gut microbiota composition upon gluten-free diet intervention baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: fecal calprotectin baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: plasma cytokines: IL-1beta baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: fecal human beta defensin 2 baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: fecal chromogranin A baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: fecal short chain fatty acids: propionate baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: plasma citrulline baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: fecal short chain fatty acids: acetate baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: fecal short chain fatty acids: butyrate baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: fecal short chain fatty acids: valerate baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: fecal short chain fatty acids: caproate baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: plasma cytokines: IL-6 baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: plasma cytokines: IL-8 baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: plasma cytokines: IL-10 baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: plasma cytokines: IL-12 baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
Secondary Changes in gut associated biomarker levels: plasma cytokines: TNFalpha baseline, 4 weeks gluten-free diet and 4 weeks habitual diet
See also
  Status Clinical Trial Phase
Recruiting NCT05560087 - Association of PeRiODontal Disease and gUt Microbiome With Coronary artEry Disease (PRODUCE Study)
Completed NCT04222699 - Cultures Before and After Decolonization in Community Dwelling Adults With Current S. Aureus Colonization Phase 4
Completed NCT02392182 - Lung HIV Microbiome Project (Michigan Site) N/A
Completed NCT04597502 - The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties N/A
Completed NCT04596722 - Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties N/A
Completed NCT05150184 - Isolation and Characterization of Multiple Microbial Species From Diverse Healthy Adults
Recruiting NCT03942159 - Modification of the Human Colon and Oral Microbiome by Allogenic HSCT
Completed NCT04335526 - A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome Profiles Phase 1
Completed NCT03668015 - Xylitol and Sorbitol Effects on the Oral Microbiome N/A
Completed NCT03157687 - Detection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic Inflammation
Not yet recruiting NCT04841694 - Oral Probiotics on the Shift in Gut Microbiome and Skin Carotenoid Levels N/A
Enrolling by invitation NCT03231332 - Effects of H.Pylori Eradication on Microbiome Phase 4
Completed NCT03181269 - Human Milk and Infant Intestinal Microbiome Study N/A
Completed NCT03543605 - Clinical/Microbiological Impact of a Specific Antimicrobial Stewardship Program for Nursing Homes N/A
Completed NCT01496898 - Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement N/A
Terminated NCT03907501 - Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation N/A
Completed NCT03809260 - A Clinical Trial for Analysis of Intestinal Microbiome Affecting PK, PD, and Safety of Metformin N/A
Completed NCT04218799 - Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans Phase 4
Completed NCT03581812 - Snack Foods and Their Impact on Gastrointestinal Microbiology, Function and Symptoms N/A
Withdrawn NCT02407184 - Potential Restoration of the Infant Microbiome N/A